Promoting safer clozapine dosing in the Americas

Braz J Psychiatry. 2022 Sep 22;44(4):363-365. doi: 10.47626/1516-4446-2021-0041.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Americas
  • Antipsychotic Agents* / adverse effects
  • Clozapine* / adverse effects
  • Humans

Substances

  • Antipsychotic Agents
  • Clozapine